The global demand for Mobile Continuous Glucose Monitoring Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Continuous Glucose Monitoring (CGM) is a procedure to examine the glucose level in the blood. It is used for diabetes diagnosis, monitoring and management. The conventional technique for glucose monitoring is to draw blood from the finger and applying the blood to a chemically active test-strip for further testing. Conventional glucose gauges are extensively used devices in the healthcare sector. Though, strict monitoring of blood glucose level is essential to test variations in the glucose level at regular intervals. A CGM is, thus, an intelligent medical tool that provides consistent data regarding glucose level and delivers real-time data on the glucose amounts over the period of time. The CGM tool shows data automatically, which is obtained at an interval of every five minutes enabling the finger-stick lesser frequent. Such an instrument is used with or without an insulin pump which makes it more portable.
The global Mobile continuous glucose monitoring market is prominently driven by the rising number of people enduring diabetes and a few other diseases that require continuous monitoring of the glucose level in the blood. As a consequence, diabetes surveillance has served as the main priority of the healthcare sector. Such boosting plurality of diabetes is anticipated to give high development chances to crucial market players, further stimulating the market growth. Besides, ripening healthcare facilities and boosting awareness regarding individual health focus are other components figured to strengthen the market growth in the forecast period.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of mobile continuous glucose monitoring.
The entire mobile continuous glucose monitoring market has been sub-categorized into type, application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Non-Invasive (Exfoliation)
- Self/Home Care
- Hospital & Clinics
This section covers regional segmentation which accentuates on current and future demand for mobile continuous glucose monitoring market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Refractive Surgery Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mobile continuous glucose monitoring market include Dexcom, Medtronic, LifeScan, Roche, Insulet, Abbott Laboratories, Panasonic Healthcare, Echo Therapeutics, Tandem Diabetes Care, GlySens. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.